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Acute hemorrhagic pneumonia caused by Streptococcus zooepidemicus has emerged as a major disease of shelter dogs and grey-
hounds. S. zooepidemicus strains differing in multilocus sequence typing (MLST), protective protein (SzP), and M-like protein
(SzM) sequences were identified from 9 outbreaks in Texas, Kansas, Florida, Nevada, New Mexico, and Pennsylvania. Clonality
based on 2 or more isolates was evident for 7 of these outbreaks. The Pennsylvania and Nevada outbreaks also involved cats.
Goat antisera against acutely infected lung tissue as well as convalescent-phase sera reacted with a mucinase (Sz115), hyaluroni-
dase (HylC), InlA domain-containing cell surface-anchored protein (INLA), membrane-anchored protein (MAP), SzP, SzM, and
extracellular oligopeptide-binding protein (OppA). The amino acid sequences of SzP and SzM of the isolates varied greatly. The
szp and szm alleles of the closely related Kansas clone (sequence type 129 [ST-129]) and United Kingdom isolate BHS5 (ST-123)
were different, indicating that MLST was unreliable as a predictor of virulence phenotype. Combinations of conserved HylC and
serine protease (ScpC) and variable SzM and SzP proteins of S. zooepidemicus strain NC78 were protectively immunogenic for
mice challenged with a virulent canine strain. Thus, although canine pneumonia outbreaks are caused by different strains of S.
zooepidemicus, protective immune responses were elicited in mice by combinations of conserved or variable S. zooepidemicus
proteins from a single strain.
Rarely isolated from normal healthy dogs, strains of the zoo-notic Streptococcus zooepidemicus (Streptococcus equi subsp.
zooepidemicus) have caused epizootics of highly fatal hemorrhagic
pneumonia in racing greyhounds and dogs in shelters and re-
search colonies in North America, the United Kingdom, and Ko-
rea (1–5). At least 2 shelter epizootics were shown to be caused by
single clones of S. zooepidemicus (3, 4). Multilocus sequence typ-
ing (MLST) of isolates from persistent outbreaks in a United
Kingdom shelter revealed the predominance of sequence type 10
(ST-10) from 1999 to 2002 and ST-62 from 2007 to 2010 (6). The
clonality of shelter epizootics of S. zooepidemicus pneumonia in
dogs contrasts with the situation usually observed in horses, in
which a single serovar randomly derived from multiple serovars
in the tonsillar complex is aspirated and infects the lower respira-
tory tract devitalized by virus infection or extended transportation
(7). However, outbreaks of equine respiratory disease caused by
specific clones of S. zooepidemicus are occasionally observed (8, 9).
These clonal outbreaks differed from those observed in dogs in
that equine mortality rates were very low. Disease in dogs is char-
acterized by fibrinosuppurative necrotizing hemorrhagic changes
in the lung, vascular damage with hemorrhage, pleural effusion,
and bacterial emboli in blood vessels (4).
The clinical syndrome consisting of rapid onset of pyrexia, hypo-
volemia, and coagulopathy superficially resembles toxic shock syn-
drome in humans, wherein proinflammatory cytokines are released
following the interaction of superantigenic pyrogenic exotoxins with
T lymphocytes. Although tumor necrosis factor alpha (TNF-), in-
terleukin-8 (IL-8), and IL-6 mRNA levels are elevated in the lung
tissue of dogs with S. zooepidemicus pneumonia, the majority (64%)
of isolates from cases in the United Kingdom and the United States
were negative for known superantigen genes and lymphocyte mito-
genicity (5; C. Mérant and J. F. Timoney, unpublished data). Lungs of
acutely affected dogs contain large numbers of extracellular cocci,
indicating rapid proliferation and evasion of clearance mechanisms.
Bacteremia/septicemia, as evidenced by ecchymotic hemorrhage in
lymph nodes and parenchymatous organs including kidneys, is also
present. Virulence factors of importance in pathogenesis and associ-
ated acquired immune responses are largely unknown. Studies of
these aspects are complicated by the genetic diversity of the S. zooepi-
demicus population. The aims of the studies described in this report
were (i) to genetically characterize isolates of S. zooepidemicus from
outbreaks of canine respiratory disease in the United States, (ii) to
identify S. zooepidemicus proteins present in diseased lungs and/or
involved in acquired immune responses of convalescent dogs follow-
ing natural infection, and (iii) to evaluate selected combinations of
recombinant S. zooepidemicus proteins as protective immunogens
in mice challenged with a virulent canine isolate from a shelter
epizootic.
MATERIALS AND METHODS
Isolates of S. zooepidemicus. Strains of S. zooepidemicus were isolated
from the lungs of animals in 9 outbreaks of acute respiratory disease in
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greyhounds, shelter dogs, and other dogs in Texas (outbreaks 1 and 2),
Kansas (outbreaks 3 and 4), Florida (outbreak 5), Nevada (outbreak 6),
New Mexico (outbreaks 7 and 8), and Pennsylvania (outbreak 9). The
years of isolation ranged from 1992 to 2011 (Table 1). All isolates were
nonmucoid at 37°C, belonged to Lancefield group C, and fermented lac-
tose and sorbitol but not trehalose.
Culture media. Streptococci were cultured overnight at 37°C on colis-
tin-nalidixic acid (CNA) blood agar and in Todd Hewitt broth (THB)
with 0.2% yeast extract.
Sera. Sera from 2 convalescent dogs (Angel and Lockjaw) and 23 un-
affected dogs were collected from the Pennsylvania shelter in April 2010.
Sera from Angel and Lockjaw were not cultured, but the dogs had clinical
evidence of pneumonia and nasal hemorrhage similar to that for kennel
mates that died and had positive cultures for S. zooepidemicus. Antisera to
streptococcal antigens in the lungs of 2 dogs (Boomer and Jack) that died
of acute hemorrhagic pneumonia caused by S. zooepidemicus (ST-315)
were prepared separately in two 4-month-old goats. Affected lung tissue
(5 g) was ground in phosphate-buffered saline (PBS) (pH 7.2) in a Ten-
broeck grinder, and particulate material was removed by centrifugation at
5,000  g for 20 min. The extracts were then heated at 56°C for 1 h to
inactivate the remaining bacteria. Inactivation was confirmed by plating
100-l aliquots on CNA blood agar. QuilA (60 g/1.5 ml) and merthio-
late (1:10,000) were then added. The extracts were administered subcuta-
neously in a dose volume of 2 ml. A second inoculation was given 14 days
later, and sera were harvested at 28 days. The immunization protocol was
approved by the University of Kentucky Animal Care Committee.
Extraction of surface proteins and precipitation of secreted pro-
teins. Surface-anchored proteins of S. zooepidemicus strain 653 (ST-315)
cultured overnight in THB were obtained as described elsewhere (9). Pro-
teins secreted into the culture supernatant were precipitated with the ad-
dition of an equal volume of saturated ammonium sulfate and overnight
stirring at room temperature. After centrifugation at 10,000  g for 30
min, the precipitate was dissolved in 200 l of 20 mM Tris (pH 8.0).
Gel electrophoresis and immunoblotting. Gels with proteins sepa-
rated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) were treated with 0.3% Coomassie brilliant blue R-250. Stained
bands were excised and identified by tandem mass spectrometry (MS/MS)
analysis, as described elsewhere (9). Briefly, gel slices were vacuum dried,
alkylated by addition of 50 mM NH4HCO3 containing 50 mM iodoacet-
amide, and incubated for 30 min in the dark at room temperature. Pro-
teins were digested in the gel on ice for 1 h by using proteomics-grade
trypsin at a concentration of 20 ng/l. Extracted peptides were then ana-
lyzed with an Applied Biosystems 4800 matrix-assisted laser desorption
ionization–time of flight/time of flight (MALDI TOF/TOF) proteomics
analyzer.
Separated proteins were transferred to nitrocellulose membranes as
described previously (9). The membranes were then incubated with con-
valescent-phase serum (1:200) from Angel, following her recovery from
pneumonia caused by a ST-315 strain in the Pennsylvania shelter. After
washing, peroxidase-conjugated protein A (diluted 1:1,000) was added
and incubated for 1 h at 37°C. Bound conjugate was detected by using
4-chloro-1-naphthol.
Recombinant proteins. Recombinant proteins of S. zooepidemicus
strain NC78, a clone (ST-307) responsible for an epizootic of equine re-
spiratory disease in New Caledonia in 1997 and 1998, were prepared as
described elsewhere (10). Clinical signs in affected horses included cough,
mucopurulent nasal discharge, and abnormal lung sounds. His-tagged
fusion proteins were purified, and their purity was checked by SDS-PAGE.
Enzyme-linked immunosorbent assay. Levels of serum antibodies to
secreted and surface-anchored proteins and to recombinant enolase, M-
like protein (SzM), oligopeptide-binding protein (OppA), membrane-
anchored protein (MAP), putative ferric siderophore receptor (FSR), InlA
domain-containing cell surface-anchored protein (INLA), Sz115, MAC
family protein IdeZ (SzMAC), serine protease (ScpC), protective protein
(SzP), hyaluronidase (HylC), alkyl hydroperoxide reductase subunit C
(AhpC), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and
streptokinase (SKC) were measured as described elsewhere (10). Briefly,
wells of 96-well polystyrene plates (Costar) were coated separately in trip-
licate with 1 g of secreted, surface, or recombinant protein and blocked
with 5% nonfat dry milk powder. Sera (1:200) were added in 100-l
aliquots and incubated for 2 h at 37°C. After washing, wells were incu-
bated for 1 h with 100 l peroxidase-conjugated protein A (1:4,000;
Zymed, San Francisco, CA) and developed with 0.07% o-phenylenedi-
amine (Sigma, St. Louis, MO). Absorbances were read at 490 nm. Wells
TABLE 1 Isolates of Streptococcus zooepidemicus from outbreaks of pneumonia in dogs and cats
Outbreak Isolate Place (yr) MLST
Identity (%)a
CommentsSzP SzM
1 2201b Texas (1992) ST-169 77.08 (N1HV1c, 8 PEPK) 57.37 Pneumonia, greyhound
2 2295b Texas (1993) ST-162 77.49 (N1HV4, 10 PEPK) 48.85 Pneumonia, greyhound
3 985, 997b Kansas (2005) ST-129 89.47 (N2HV2, 10 PEPK) 23.92 Hemorrhagic pneumonia,
greyhound
4 007, 782b Kansas (2006) ST-2 83.16 (N2HV3, 8 PEPK) 24.96 Hemorrhagic pneumonia,
greyhound
5 42, 43,b 44, 45 Florida (2006) ST-172 86.68 (N2HV4, 11 PEPK) 30.68 Hemorrhagic pneumonia,
greyhound; influenza
virus isolated
6 1150 K,b L, M Nevada (2007) ST-173 83.95 (N2HV5, 9 PEPK) 31.14 Hemorrhagic pneumonia,
shelter dogs; no virus
isolated
47Ab (cat) Nevada (2007) ST-316 84.21 (N2HV5, 9 PEPK) 31.14 Bacteremia, shelter cat
7 800,b 785b New Mexico (2008) ST-318 83.49 (N2HV2, 12 PEPK) 30.99 Pneumonia, service dogs
8 566,b Sableb New Mexico (2011) ST-317 86.68 (N2HV4, 11 PEPK) Pseudogene Pneumonia, house dogs
9 738-09,b Jack, Tiger,b Boomer,b
653,b 457b (cat), 629b (cat)
Pennsylvania (2009–2010) ST-315 91.57 (N2HV2, 10 PEPK) 31.51 Hemorrhagic pneumonia,
shelter dogs and cats
Dartb (cat) Pennsylvania (2009–2010) ST-315 82.63 (N2HV2, 3 PEPK) 31.51 Pneumonia, shelter cat
BHS5 United Kingdom (1999) ST-123 100 (N2HV2, 11 PEPK) 100 Pneumonia, shelter dog
a Amino acid identity shared with S. zooepidemicus strain BHS5.
b The SzP and SzM sequences of the isolates were obtained.
c N-terminal and hypervariable motifs.
Streptococcal Pneumonia in Dogs
September 2014 Volume 21 Number 9 cvi.asm.org 1247
 on D
ecem
ber 7, 2015 by U
N
IV
 O
F
 K
E
N
T
U
C
K
Y
http://cvi.asm
.org/
D
ow
nloaded from
 
without coating antigen and serum served as negative controls for back-
ground reactivity. Mouse sera were titrated to endpoints against the ap-
propriate protein using serial dilutions of 1:50 to 1:102,400. Goat antisera
to extracts of S. zooepidemicus-infected dog lungs were assayed at a dilu-
tion of 1:100.
Multilocus sequence, szp, and szm typing. Multilocus sequence typ-
ing (MLST) based on arcC, nrdE, proS, spi, tdk, tpi, and yqiL was per-
formed (11) on canine and feline S. zooepidemicus isolates from each
outbreak, and sequence types (STs) were assigned (http://pubmlst.org
/szooepidemicus). The szp and szm sequences were also amplified using
the forward and reverse primers IGSzPF (5=-CTT GCT AAA GTA ATG
GTT GAC-3=) and IGSzPR (5=-GTT TGT GAG CAA GGC TTA GTC-3=)
(12) and SzMF (5=-ATA AAG TTC CTG TCA TTA-3=) and SzMR (5=-
CAA CAG ACA GGA GAC TGT TGC-3=), respectively; amplicons (1,212
and 1,929 bp, respectively) were then sequenced (Eurofin MWG Operon,
Huntsville, AL), and amino acid sequences were predicted.
Mouse immunization and challenge. Three groups of 10 outbred,
8-week-old, ICR (CD-1):Hsd, female mice (12 to 14 g) bred in a Univer-
sity of Kentucky laboratory animal facility from breeding stock supplied
by Harlan Laboratories (South Easton, MA) were immunized by subcu-
taneous inoculation with 20 g of recombinant SzM, SzM plus SzP, or
HylC plus ScpC in 0.15 ml PBS with 20 g of QuilA (Desert King Inter-
national, San Diego, CA), as described previously (10). Proteins in the
three vaccines were selected because of demonstrated superior protective
immunogenicity in mice and, with the exception of HylC, strong reactiv-
ity with convalescent-phase canine sera (10). The combinations were de-
signed to test the hypothesis that combinations of conserved (HylC plus
ScpC) or variable (SzM plus SzP) proteins would be protective. Two sub-
cutaneous booster doses of 20 g of each recombinant protein were given
2 weeks apart. Five mice immunized with sterile PBS plus QuilA served as
controls.
Two weeks after the final booster inoculation, the vaccinated and con-
trol groups of mice were challenged with 3  106 CFU (female mice) or
3  105 CFU (male mice) of log-phase cultures of S. zooepidemicus strain
738-09, administered intraperitoneally in 0.15 ml PBS. Differences in
challenge inocula reflected previously determined differences in the sus-
ceptibility of male and female mice to S. zooepidemicus challenges (10).
Morbidity (depression and rough coat) and deaths in each group were
recorded at 8-h intervals for 8 days following experimental infection. Mice
were euthanized promptly after illness was apparent, and heart blood was
cultured on CNA blood agar and assayed for antibodies to S. zooepi-
demicus proteins. Cumulative morbidity curves were prepared for vacci-
nated and control mice. The immunization-challenge protocol was ap-
proved by the University of Kentucky Animal Care Committee.
Statistical analyses. Fisher’s exact test was used to test the significance
of differences in morbidity rates between groups of vaccinated and control
mice. SigmaPlot 11.0 was used for box-and-whisker plots.
Nucleotide sequence accession numbers. The full-length szm and szp
gene sequences of representative canine and feline S. zooepidemicus iso-
lates from each outbreak were submitted to the NCBI GenBank database
under accession numbers KF214267 to KF214286 and KF768745 to
KF768759.
RESULTS
Strains and clinical presentations. Nine different S. zooepi-
demicus STs were identified in the study (Table 1). Isolates 2201
and 2295 from cases of pneumonia in greyhounds in Texas in 1992
and 1993 (outbreaks 1 and 2) were unrelated ST-169 and ST-162.
Outbreaks 3 and 4, involving pneumonia in Kansas, were caused
by isolates of ST-129 in 2005 and ST-2 in 2006. These isolates also
expressed different SzP and SzM proteins. ST-2 isolates were from
5 greyhounds sampled in outbreak 4, involving coughing among
15 animals. An isolate of ST-2 (S. zooepidemicus strain 782) was
also obtained from a single case of hemorrhagic pneumonia in a
greyhound in a different kennel. Isolates 997 and 985 (ST-129)
were from acute outbreak 3, which occurred in a greyhound ken-
nel in 2005 and was characterized by epistaxis and death (Table 1).
S. zooepidemicus strains 42, 43, 44, and 45 (ST-172) were cultured
from greyhounds in Florida (in outbreak 5) that developed hem-
orrhagic bronchopneumonia and died shortly after coinfection
with the H3N8 canine variant of equine influenza virus (13).
S. zooepidemicus strains 1150 K, L, and M (ST-173) were iso-
lated in outbreak 6, which involved acute hemorrhagic pneumo-
nia in more than 1,000 mixed-breed dogs in an animal shelter in
Nevada (3). S. zooepidemicus strain 47A (ST-316) from a cat
spleen was obtained from the same shelter and was a single-locus
(proS) variant of ST-173 (Table 1). Serological and PCR investi-
gations revealed no evidence of known viral pathogens during this
shelter outbreak. S. zooepidemicus strains 800 and 785 (ST-318)
were from outbreak 7, which involved coughing and pneumonia
in service dogs on a horse ranch in New Mexico in 2008. Isolates
566 and Sable (ST-317) were from cases of pneumonia in com-
panion housedogs in New Mexico in 2011 (outbreak 8). S. zooepi-
demicus isolates from Pennsylvania were from outbreak 9; this
outbreak of hemorrhagic pneumonia in shelter dogs and cats be-
gan in spring 2009 and continued into late summer 2010. Isolates
from multiple dogs in 2009 and from dogs and cats in 2010 were
identified as ST-315 (Table 1).
Clinical presentations included rapid onset of cough, pyrexia,
respiratory distress, hemorrhagic nasal discharge, lethargy, and
rapid deterioration, with death in 1 or 2 days. Deaths in shelter
outbreaks continued for months and involved many hundreds of
dogs. Affected cats exhibited respiratory signs similar to those ob-
served in dogs. Necropsy findings included hemothorax and hem-
orrhagic pneumonia. Some dogs had acute necrotizing sinusitis
and rhinitis. Histologically, lesions were those of peracute fibrino-
suppurative pneumonia, with obliteration of alveolar spaces with
neutrophils. Gram-positive cocci were found in large numbers in
alveolar spaces and in macrophages. Affected lungs, spleens, and
heart blood yielded pure cultures of nonmucoid S. zooepidemicus.
Attempts to implicate a viral etiology by culture, PCR, or serology
were unsuccessful, with the exception of greyhounds in the Flor-
ida outbreak.
Streptococcal proteins in infected dog lung. Streptococcal
proteins recognized by antibodies in goat antisera raised against
extracts of acutely infected lungs from Boomer and Jack are shown
on Table 2. The objectives were to detect immunogenic S. zooepi-
demicus proteins expressed in vivo in acutely infected lung tissue
and to correlate the results with those obtained using convales-
cent-phase sera from recovered dogs. Antibody responses in one
or both goat antisera included all proteins except SKC and FSR.
Responses to lung tissue from Boomer were of greater magnitude
and broader specificity. This might have been due to differences in
the levels of proteins in each lung or to differences in the respon-
siveness of each goat. The background activity of preimmune sera
for some proteins in the panel suggested nonspecific binding or,
less likely, prior exposure of the goats to S. zooepidemicus.
Reactivities of canine convalescent-phase serum. The immu-
noblot in Fig. 1 shows the reactivity of secreted proteins of canine
isolates of S. zooepidemicus with convalescent-phase serum from
Angel from the Pennsylvania epizootic. Peak lists from the MS/MS
spectra of peptides in tryptic digests of a reactive band at 115 kDa
revealed the amino acid sequence of a putative metalloprotease
with mucinase activity (Sz115) (see Table S1 in the supplemental
Velineni et al.
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material) common to all 8 STs. The 47-kDa band was identified as
enolase (see Table S1 in the supplemental material).
Figure 2 shows the specificities of antibodies in a set of sera
from 23 unaffected dogs and in convalescent-phase sera from An-
gel and Lockjaw from the Pennsylvania shelter. Twelve of 14 re-
combinant proteins were strongly reactive with convalescent-
phase serum from Angel. Both convalescent-phase sera reacted
strongly with secreted and mutanolysin-extracted proteins of S.
zooepidemicus strain 653 (ST-315), which was responsible for the
Pennsylvania epizootic. Sera from 23 healthy dogs residing in the
Pennsylvania shelter between August 2009 and July 2010 were
generally unreactive with proteins in the panel, although some
sera reacted strongly (enzyme-linked immunosorbent assay
[ELISA] optical density [OD] values of 1.0) with 3 or more
proteins, suggesting exposure to S. zooepidemicus. Serum from
one of the 23 unaffected dogs reacted strongly with preparations
of both secreted and mutanolysin-extracted surface proteins of S.
zooepidemicus strain 653. It also reacted with recombinant Sz115
and FSR but reacted weakly or undetectably with 10 other S.
zooepidemicus proteins.
Sequences of SzP and SzM. The SzP amino acid sequences of
isolates of each S. zooepidemicus sequence type varied greatly. All 5
hypervariable (HV) regions were represented and, with the excep-
tion of the Texas isolates, were combined with N2 N-terminal
sequences (Table 1). PEPK (proline-glutamic acid-proline-lysine)
repeat numbers ranged from 4 to 12. An isolate from a cat in the
Pennsylvania outbreak that was otherwise identical to the clone
from affected dogs showed a reduction in the number of PEPK
repeats from 10 to 3. SzP and SzM sequences in isolates from
specific outbreaks were identical, consistent with clonality of the S.
zooepidemicus strains involved. Comparison of the SzM sequences
of isolates from each outbreak with the SzM sequence of S. zooepi-
demicus strain BHS5 isolated in the United Kingdom revealed
identities that ranged from 23.92 to 57.37%. The BHS5 strain was
TABLE 2 Specificities of antibodies raised in 2 goats against separate
lung extracts from dogs (Boomer and Jack) that died of hemorrhagic
pneumonia caused by S. zooepidemicus ST-315 in Pennsylvania
Protein
OD at 490 nma
Boomer Jack
OppA 0.32 0.08
INLA 0.34 0.00
SKC 0.05 0.05
FSR 0.05 0.05
Sz115 0.41 0.05
IdeZ (SzMAC) 0.02 0.16
ScpC 0.29 0.21
SzM 0.30 0.06
SzP 0.26 0.15
GAPDH 0.15 0.00
AhpC 0.11 0.12
MAP 0.25 0.51
HylC 0.50 0.10
a OD values are means of 3 replicates, following subtraction of the OD values of sera
harvested prior to immunization.
FIG 1 Immunoreactive secreted proteins from clones of S. zooepidemicus
from outbreaks of pneumonia in dogs and greyhounds in different regions of
the United States. Proteins secreted in overnight cultures in THB were precip-
itated with 50% ammonium sulfate, dissolved in PBS, and transferred to ni-
trocellulose membranes following SDS-PAGE (12%). The blot was probed
with convalescent-phase serum (1:200) from Angel (Pennsylvania), infected
with ST-315. Lane 1, S. zooepidemicus strain 007 (Kansas); lane 2, S. zooepi-
demicus strain 985 (Kansas); lane 3, S. zooepidemicus strain 43 (Florida); lane 4,
S. zooepidemicus strain 2201 (Texas); lane 5, S. zooepidemicus strain 2295 (Tex-
as); lane 6, S. zooepidemicus strain 800 (New Mexico); lane 7, S. zooepidemicus
strain 1150K (Nevada); lane 8, S. zooepidemicus strain 653 (Pennsylvania).
Molecular masses (kDa) are shown on the left. The positions of metallopro-
teinase/mucinase (115 kDa) and enolase (47 kDa) are shown on the right. The
positions of metalloproteinase/mucinase (115 kDa) and enolase (47 kDa) are
shown on the right.
FIG 2 (Upper) Levels of antibodies (ELISA OD values) reactive with each of
16 recombinant proteins of S. zooepidemicus strain NC78 in 1:200 dilutions of
convalescent-phase sera from Angel (Œ) and Lockjaw (o), which survived
infection in the Pennsylvania shelter outbreak. Each symbol represents the
mean OD value of 3 replications of the ELISA for that protein. (Lower) Anti-
body levels for 23 dogs that remained healthy in the shelter for 11 months
during the pneumonia epizootic. Mut., mutanolysin-extracted surface pro-
teins of S. zooepidemicus; CSP, culture supernatant secreted proteins of S.
zooepidemicus. , outlier values. Horizontal lines, median values; error bars,
90th and 10th percentiles.
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chosen for identity comparisons because of access to its genomic
sequence (14). Interestingly, although its sequence type (ST-123)
included 6 loci common to isolates 985 and 997 (ST-129) from
greyhounds from the outbreak in Kansas in 2005, the SzP and SzM
sequences of these isolates were not shared. Moreover, the Kansas
clone lacked szeF, which was found in BHS5.
Figure 3 shows the diversity of tandem repeat sequences in SzM
(15). Texas isolates from different outbreaks in 1992 and 1993
shared the same tandem repeat structure; szm from the 2011 New
Mexico isolate was a pseudogene and lacked recognizable tandem
repeats.
Protective efficacy of SzM, SzM plus SzP, and HylC plus
ScpC. Mice immunized subcutaneously with a combination of
HylC plus ScpC or SzM plus SzP were significantly (P  0.02)
resistant to intraperitoneal challenge with S. zooepidemicus strain
738-09 (ST-315), compared with unimmunized controls (Table
3). Only 50% of mice immunized with SzM alone were resistant
(P  0.1). Titers of serum antibodies from groups of immunized
mice 7 days after challenge ranged from 1:12,800 for SzP to
1:51,200 for SzM and ScpC. Titers of HylC-specific antibodies
were 1:25,600 (Table 3), which is evidence that the immunization
protocol was highly effective. ICR (CD-1):Hsd mice were used
because this strain had been shown to be susceptible to challenge
with different strains of S. zooepidemicus (10).
DISCUSSION
Sporadically recognized in the late 1970s as a serious and highly
fatal disease of racing greyhounds in the United States, acute fatal
pneumonia with septicemia caused by S. zooepidemicus has re-
cently emerged as a major disease in shelter dogs in North America
and elsewhere (1, 3, 4, 16). Epizootics involving hundreds of ani-
mals in shelters in Nevada, Pennsylvania, New York, and Wiscon-
sin have required intensive control measures, including complete
depopulation and disinfection. Transmission is rapid under con-
ditions of crowded housing, the stress of regrouping, and confine-
ment in unfamiliar surroundings. S. zooepidemicus is rarely iso-
lated from healthy dogs (6, 17, 18) but is a normal commensal
organism of the tonsillar complex of horses (19). The sources of S.
zooepidemicus clones for canine epizootics are unknown. Possibil-
ities include encounters of dogs, prior to admission to the shelter,
with infected wild animals or birds, since deaths caused by S.
zooepidemicus have been reported for chickens, foxes, and mink
(20–22).
The clonal nature of outbreaks of S. zooepidemicus pneumonia
in shelters was first recognized in Nevada and was confirmed in a
Korean outbreak (3, 4). The MLST, SzP, and SzM data based on
multiple randomly selected isolates from the Nevada and Penn-
sylvania outbreaks are consistent with these earlier conclusions.
Outbreaks in greyhound kennels in Kansas and Florida and
among service dogs on a ranch in New Mexico also appeared to be
clonal, although findings were based on small numbers of isolates.
Only one isolate was submitted from each of 2 separate outbreaks
among greyhounds in Texas in 1992 and 1993. Based on MLST,
SzP, and SzM analyses (Table 1), the S. zooepidemicus clones re-
sponsible for each of the US outbreaks were different from each
other and from BHS5, a United Kingdom isolate (14). S. zooepi-
demicus strains 985 and BHS5 have been reported to be closely
related, yet their SzM sequences show low levels of identity (14).
Moreover, the szeF sequence found in S. zooepidemicus strain
BHS5 is missing from S. zooepidemicus strain 985. These observa-
tions highlight both the limitations of the use of MLST alone in
epidemiological studies and the importance of characterizing vir-
ulence genes in defining clones involved in epizootics. SzM has
been shown to be a protective antigen in mice and to activate
equine plasminogen. SzeF shares 59% amino acid identity with
streptococcal pyrogenic exotoxin H (SPEH) of S. equi and was
FIG 3 Tandem repeats in SzM proteins of S. zooepidemicus clones from outbreaks of canine pneumonia. Sig.pep, N-terminal signal peptide.
TABLE 3 Resistance of mice vaccinated with recombinant proteins of S. zooepidemicus strain NC78 (ST-307) to intraperitoneal challenge with S.
zooepidemicus strain 738-09 (ST-315) from outbreak of hemorrhagic pneumonia in shelter dogs in Pennsylvania
Protein(s)
Challenge
(CFU/mouse)a
No. of survivors/
total no.b Resistance (%) Pc Antibody titer(s)
SzM 106 (female) 5/10 50 0.1 1:51,200
SzM  SzP 105 (male) 8/10 80 0.02 SzM, 1:25,600; SzP, 1:12,800
HylC  ScpC 106 (female) 9/10 90 0.01 HylC, 1:25,600; ScpC, 1:51,200
Control 106 (female) 0/5 0
a Challenge CFU administered to male mice were lower than those administered to female mice based on the previously determined greater susceptibility of male mice to
intraperitoneal inoculation of S. zooepidemicus (10).
b Eight days postchallenge.
c For difference in morbidity between vaccinated and control mice.
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found in 31% of equine S. zooepidemicus isolates in the United
Kingdom. Its role in virulence is unknown.
The clinical features and lesions of fibrinosuppurative necro-
tizing pneumonia common to all outbreaks indicate that S. zooepi-
demicus clones of varied genetic backgrounds express factors in
common that directly or indirectly cause acute blood vessel dam-
age, necrosis, erythrocyte exudation, and fibrin deposition in ca-
nine lungs. Direct necrotizing effects on nasal and sinus mucosal
surfaces have also been reported (3). The large numbers of extra-
cellular streptococci in affected lungs suggest rapid proliferation
and evasion of innate immune responses. Heavy infiltration of
neutrophils, many with intracellular bacteria, suggests that this
aspect of the innate immune response is ineffective and potentially
deleterious because of bystander injury from the release of pro-
teases. A recent study of genes transcribed by S. zooepidemicus in
infected porcine lung supports the hypothesis of rapid prolifera-
tion (23). S. zooepidemicus genes associated with metabolic path-
ways, cell wall synthesis, and nutrient transport are upregulated,
as are genes for proteases such as clpP and clpB, which play roles in
resistance to stress conditions (23).
Confinement in crowded shelter environments and intense
physical activity have the potential to reduce resistance to micro-
bial invasion by triggering the release of stress hormones such as
cortisol and norepinephrine (NE). Cortisol reduces the bacteri-
cidal activity of neutrophils and downregulates the interleukin-2
receptor of T helper lymphocytes (24, 25). NE, synthesized in the
lung, has the ability to release iron from transferrin and lactofer-
rin, thereby making it available for bacterial proliferation (26–28).
The involvement of stress hormones theoretically could indirectly
explain the large numbers of streptococci located extracellularly
and in neutrophils in acutely infected lungs (3).
The reactivities of convalescent-phase sera and of antisera to
infected lung tissue provide some limited insight into proteins
expressed during infection. Convalescent-phase antibodies (Fig. 1
and 2) showed varying reactivities with a metalloprotease/muci-
nase secreted by all S. zooepidemicus clones tested. The roles of
mucinase in pathogenesis include degradation of the mucin bar-
rier lining the airways, with loss of glycocalyx barrier function.
This may facilitate invasion and provide nutrients for bacterial
growth (29, 30). Bacterial metalloproteases are known contribu-
tors to the virulence of Streptococcus pneumoniae, Staphylococcus
aureus, and Listeria monocytogenes (31).
The protective efficacies of the combinations of SzM plus SzP
and HylC plus ScpC for mice challenged with S. zooepidemicus
strain 738-09 from the Pennsylvania outbreak suggest that com-
binations of conserved or variable proteins from S. zooepidemicus
may each have vaccine potential in a heterologous challenge
model. It is important to note that the SzM and SzP proteins used
for vaccination were produced in another study using DNA se-
quences of S. zooepidemicus strain NC78 and so share limited
amino acid identity (79.95 and 24.05%, respectively) with these
proteins of S. zooepidemicus strain 738-09 (10). SzMNC78 by itself
stimulated protection in 5/10 mice against S. zooepidemicus strain
738-09, suggesting that antibodies specific for conserved epitopes
on this protein contribute to protection. Further support for the
vaccine potential of variable proteins was the reactivity of sera
from Angel and Lockjaw with both SzMNC78 and SzPNC78 (Fig. 2).
In addition, the highly conserved HylC and ScpC were previously
shown to be separately protective, in a mouse model, against a
lethal challenge with 3  104 CFU of S. zooepidemicus strain NC78
(10). These 2 antigens together protected mice against 3  106
CFU of S. zooepidemicus strain 738-09. The protective efficacy of
HylC in mice was unexpected not only because of the moderate
elevation of HylC-specific antibody levels in convalescent-phase
sera from Angel and Lockjaw but also because equine convales-
cent-phase responses to this protein tend to be less consistent than
those to other proteins (10).
Isolates 457, 629, 653, and Dart from cats with pneumonia and
bacteremia in the Pennsylvania shelter outbreaks were identical to
S. zooepidemicus clones from dogs, an indication that these clones
were not host restricted and that a primary viral agent was un-
likely. Interestingly, feline isolate 47A (ST-316) is a single-locus
(proS) variant of ST-173, which was isolated from dogs and envi-
ronmental samples at the Nevada shelter. It is also a single-locus
variant of an isolate (ST-18) from dogs with respiratory disease in
the United Kingdom in 2008 (MLST database). The proS locus of
ST-173 differs from that of ST-316 by 23 single-nucleotide poly-
morphisms, suggesting recent lateral gene transfer and recombi-
nation rather than mutation in the locus (32).
Outbreaks of hemorrhagic pneumonia in shelter and kenneled
dogs and greyhounds are each caused by clones of nonmucoid S.
zooepidemicus that differ in MLST, SzP, and SzM sequences. S.
zooepidemicus proteins detected in infected lung tissue and/or re-
active with convalescent-phase antibodies include Sz115, HylC,
SKC, SzP, SzM, SzMAC, INLA, FSR, MAP, and ScpC. Recombi-
nant HylC plus ScpC or SzM plus SzP from SzNC78 were protec-
tively immunogenic for mice challenged with a virulent dog S.
zooepidemicus strain, suggesting that combinations of conserved
or variable proteins may be effective vaccine components.
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